Folding intermediates are involved in genetic diseases?

Recent experimental data show that some human genetic diseases are due to mutations in proteins which influence their trafficking and lead to retaining of proteins in the endoplasmic reticulum or their unproper processing. In this paper a hypothesis is proposed that these mutations are connected with an incomplete protein folding, blocking it at the stage of the kinetic molten globule or even earlier. If so, the specific drugs against these diseases may be ligands and other factors which facilitate the correct protein folding.

[1]  P. Pedersen,et al.  The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide. , 1992, The Journal of biological chemistry.

[2]  E. Neufeld,et al.  A frameshift mutation in a patient with Tay-Sachs disease causes premature termination and defective intracellular transport of the alpha-subunit of beta-hexosaminidase. , 1989, The Journal of biological chemistry.

[3]  W. Lim,et al.  Structural and energetic consequences of disruptive mutations in a protein core. , 1992, Biochemistry.

[4]  D. Russell,et al.  Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit. , 1986, Science.

[5]  C. Machamer,et al.  Vesicular stomatitis virus G proteins with altered glycosylation sites display temperature-sensitive intracellular transport and are subject to aberrant intermolecular disulfide bonding. , 1988, The Journal of biological chemistry.

[6]  A. Ullrich,et al.  Immunoglobulin heavy chain-binding protein binds to misfolded mutant insulin receptors with mutations in the extracellular domain. , 1992, The Journal of biological chemistry.

[7]  J. King,et al.  Temperature-sensitive mutants blocked in the folding or subunit assembly of the bacteriophage P22 tail spike protein: II. Active mutant proteins matured at 30 °C , 1981 .

[8]  H. Hobbs,et al.  The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. , 1990, Annual review of genetics.

[9]  J. King,et al.  Temperature-sensitive mutants blocked in the folding or subunit assembly of the bacteriophage P22 tail spike protein: III. Inactive polypeptide chains synthesized at 39 °C , 1981 .

[10]  P. Jeffrey,et al.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.

[11]  J. Jenkins,et al.  Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells. , 1987, Oncogene.

[12]  O. Ptitsyn,et al.  The ‘molten globule’ state is involved in the translocation of proteins across membranes? , 1988, FEBS letters.

[13]  T. Creighton,et al.  Single amino acid mutations block a late step in the folding of beta-lactamase from Staphylococcus aureus. , 1985, Journal of molecular biology.

[14]  Matthew P. Anderson,et al.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive , 1992, Nature.

[15]  J. King,et al.  Formation of aggregates from a thermolabile in vivo folding intermediate in P22 tailspike maturation. A model for inclusion body formation. , 1988, The Journal of biological chemistry.

[16]  P. Horowitz,et al.  The sulfurtransferase activity and structure of rhodanese are affected by site-directed replacement of Arg-186 or Lys-249. , 1994, The Journal of biological chemistry.

[17]  K.,et al.  Heavy chain binding protein recognizes incompletely disulfide-bonded forms of vesicular stomatitis virus G protein. , 1990, The Journal of biological chemistry.

[18]  D. Lomas,et al.  The mechanism of Z α1-antitrypsin accumulation in the liver , 1993, Nature.

[19]  F. Hartl,et al.  Prevention of protein denaturation under heat stress by the chaperonin Hsp60. , 1992, Science.

[20]  S. Friend.  p53: a glimpse at the puppet behind the shadow play. , 1994, Science.

[21]  F. Hartl,et al.  Chaperonin-mediated protein folding at the surface of groEL through a 'molten globule'-like intermediate , 1991, Nature.

[22]  T. Creighton,et al.  Protein Folding , 1992 .

[23]  C. Dobson,et al.  Conformation of GroEL-bound α-lactalbumin probed by mass spectrometry , 1994, Nature.

[24]  R. Sifers.  Z and the insoluble answer , 1992, Nature.

[25]  K. Kuwajima,et al.  The chaperonin GroEL does not recognize apo-α-lactalbumin in the molten globule state , 1994, Nature Structural Biology.

[26]  A. Le,et al.  Soluble aggregates of the human PiZ alpha 1-antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesis. , 1992, The Journal of biological chemistry.

[27]  Seng H. Cheng,et al.  Intracellular protein trafficking defects in human disease. , 1992, Trends in cell biology.

[28]  A. Gronenborn,et al.  High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. , 1994, Science.

[29]  R. Jaenicke,et al.  Conformational states of ribulosebisphosphate carboxylase and their interaction with chaperonin 60. , 1992, Biochemistry.